220
Participants
Start Date
March 31, 2016
Primary Completion Date
June 30, 2017
Study Completion Date
December 31, 2017
80 Milligrams NSI-189
Orally Administered
Placebo
Orally administered
40 Milligrams NSI-189
Orally Administered
Richmond Behavioral Associates, Staten Island
Institute for Advanced Medical Research, Alpharetta
Clinical Neuroscience Solutions, Inc., Jacksonville
Clinical Neuroscience Solutions, Inc, Orlando
Clinical Neuroscience Solutions, Inc., Memphis
Midwest Clinical Research Center, LLC, Dayton
Psychiatric Medicine Associates, LLC, Skokie
St. Louis Clinical Trials, LC, St Louis
FutureSearch Trials of Dallas, Dallas
Clinical Trials of Texas, Inc., San Antonio
Clinical Trials of the Rockies, Denver
Synergy San Diego, National City
Collaborative Neuroscience Network, LLC, Garden Grove
Lead Sponsor
Neuralstem Inc.
INDUSTRY